Related Experiment Video
Updated: Apr 23, 2026
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
84.2K
Stroke and bleeding risk in atrial fibrillation.
Keitaro Senoo1, Deirdre Lane1, Gregory Yh Lip1
1University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom.
Korean Circulation Journal
|October 4, 2014
Summary
Non-valvular atrial fibrillation (AF) increases stroke risk. New oral anticoagulants (OACs) offer effective stroke prevention with improved bleeding profiles compared to warfarin, simplifying treatment decisions for at-risk patients.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- Non-valvular atrial fibrillation (AF) is a common arrhythmia linked to increased stroke risk, morbidity, and mortality.
- Oral anticoagulants (OACs) are crucial for stroke prevention in AF patients, but bleeding risks, particularly intracranial bleeds, are a concern.
- Warfarin has been the standard, but newer OACs offer comparable efficacy with improved safety profiles.
Purpose of the Study:
- To review the current landscape of stroke prevention in non-valvular AF.
- To highlight the role of newer OACs and risk stratification tools in clinical practice.
- To emphasize the importance of balancing stroke risk and bleeding risk in AF management.
Main Methods:
- Review of current clinical guidelines and literature on AF management.
- Discussion of stroke risk assessment using CHA2DS2-VASc score.
- Analysis of bleeding risk assessment using the HAS-BLED score.
Main Results:
- Four new OACs are available, offering effective stroke prevention with better bleeding profiles than warfarin.
- The CHA2DS2-VASc score identifies patients needing antithrombotic therapy.
- The HAS-BLED score aids in identifying and managing bleeding risks.
Conclusions:
- Newer OACs have simplified stroke prevention strategies in AF.
- Risk stratification using CHA2DS2-VASc and HAS-BLED scores is essential for personalized AF management.
- Careful monitoring and management of modifiable bleeding risk factors are crucial for optimizing OAC therapy.
More Related Videos
28:13Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
34.6K
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
2.8K
Related Concept Videos
01:17Hemorrhagic Stroke l: Introduction
5
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
5
01:30Venous Thrombosis IV: Nursing Management
406
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
406
01:29Hemorrhagic Stroke ll: Pathophysiology
7
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
7
01:24Disorders of Hemostasis
2.6K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.6K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.5K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.5K
01:29Venous Thrombosis III: Interprofessional Care
481
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
481